Ashot Ashkelon Industries Ltd. (TLV:ASHO)

ASLAN Pharmaceuticals Revenue

Ashot Ashkelon Industries had revenue of 121.47M ILS in the quarter ending March 31, 2025, with 24.61% growth. This brings the company's revenue in the last twelve months to 417.58M, up 21.46% year-over-year. In the year 2024, Ashot Ashkelon Industries had annual revenue of 393.59M with 20.48% growth.

• Revenue (ttm): 417.58M
• Revenue Growth: +21.46%
• P/S Ratio: 3.82
• Revenue / Employee: 817.19K
• Employees: 511
• Market Cap: 1.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	393.59M	66.91M	20.48%
Dec 31, 2023	326.68M	10.81M	3.42%
Dec 31, 2022	315.87M	-26.20M	-7.66%
Dec 31, 2021	342.07M	34.64M	11.27%
Dec 31, 2020	307.44M	9.96M	3.35%